Autonomix Medical Inc (AMIX) Stock Price, Quote & News

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices

Sector: Healthcare

Phone: 713 588 6150

Website: autonomix.com

Address:

21 Waterway Avenue, Suite 300, The Woodlands, United States

focafoca99 Jun. 10 at 1:22 PM

$AMIX highlights its growing scientific and clinical recognition as its nerve‑sensing platform secures multiple conference abstracts and a

0 · Reply

dwhall5056 Jun. 10 at 1:21 PM

$AMIX Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology ... https://ir.autonomix.com/autonomix-medical-announces-release-of-new-ceo-corner-segment-highlighting-global-scientific-and-clinical-recognition-of-platform-technology/

1 · Reply

coolmate25 Jun. 4 at 5:52 PM

$AMIX News after news but still down ? I mean seriously? Can't believe what are these big whales waiting for ?

1 · Reply

coolmate25 Jun. 4 at 2:01 PM

$AMIX

0 · Reply

coolmate25 Jun. 4 at 1:25 PM

$AMIX

1 · Reply

coolmate25 Jun. 2 at 4:27 PM

$AMIX Autonomix medical may be granted an additional 180-day period by July 13 from nasdaq if they apply soon and this might trigger the price to $2 .

1 · Reply

coolmate25 Jun. 1 at 7:25 PM

$AMIX There's always this one Mother trucker that sells when it's finally breathing lol but anyway soon things will be different.

0 · Reply

coolmate25 Jun. 1 at 6:57 PM

$AMIX Good earnings soon , also the De-Novo news can come at anytime .

0 · Reply

d_risk May. 29 at 11:49 AM

$AMIX - Autonomix Medical, Inc. - 10K - Updated Risk Factors AMIX flags fresh equity-market risks: thin small-cap tech coverage and negative analyst calls could amplify already high stock volatility, a big 2025 warrant-related share overhang may pressure the price and future raises, and Black‑Scholes cash buyback terms on Series A–C warrants could strain finances and deter takeovers. 🟢 Added 🟠 Removed https://d-risk.ai/AMIX/10-K/2026-05-27

1 · Reply

dwhall5056 May. 28 at 3:28 PM

$AMIX The Watchman, developed by Autonomix's Chief Medical Officer was sold to Boston Scientific and has generated over $1 Billion in revenue. Perhaps the same course will prevail with the new technology, perhaps much more. https://www.autonomix.com/leadership-team/ How about a 100 Billion Dollar Market Opportunity? https://www.autonomix.com/science/

0 · Reply

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Jun 4, 2026, 9:05 AM EDT - 7 days ago

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

May 27, 2026, 7:00 AM EDT - 15 days ago

Autonomix Medical Annual report: Q4 2026

2026-05-19T12:47:51.000Z - 23 days ago

Autonomix granted U.S. patent for transvascular monitoring, treatment systems

May 19, 2026, 8:30 AM EDT - 23 days ago

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

May 18, 2026, 8:45 AM EDT - 24 days ago

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Apr 29, 2026, 8:45 AM EDT - 6 weeks ago

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Apr 22, 2026, 8:42 AM EDT - 7 weeks ago

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Apr 8, 2026, 8:40 AM EDT - 2 months ago

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Mar 11, 2026, 8:40 AM EDT - 3 months ago

Autonomix Medical to Present at LSI USA '26

Mar 5, 2026, 8:45 AM EST - 3 months ago

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

2026-03-04T13:46:28.000Z - 3 months ago

Autonomix to present clinical study on Nerve Neurolysis at CRT 2026

Mar 4, 2026, 8:40 AM EST - 3 months ago

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

Feb 25, 2026, 8:30 AM EST - 3 months ago

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation

2026-02-19T13:48:07.000Z - 4 months ago

Autonomix selected to present new long-term pain mitigation data at SSO 2026

Feb 19, 2026, 8:30 AM EST - 4 months ago

Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation

2026-02-17T14:00:34.000Z - 4 months ago

Autonomix price target lowered to $2 from $5 at Maxim

Feb 11, 2026, 7:00 AM EST - 4 months ago

Autonomix Medical Quarterly report: Q3 2026

2026-01-28T13:45:46.000Z - 4 months ago

Autonomix announces final clinical data on pain mitigation in pancreatic cancer

2026-01-09T13:51:26.000Z - 5 months ago

Autonomix showcases PoC study clinical data at 2026 ASCO Symposium

Jan 9, 2026, 8:45 AM EST - 5 months ago

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Jan 9, 2026, 7:00 AM EST - 5 months ago

Autonomix Medical Slides: Investor presentation

2025-12-30T13:40:37.000Z - 5 months ago

Autonomix granted European patent on nerve-targeted therapies technology

Dec 23, 2025, 8:45 AM EST - 6 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Dec 18, 2025, 8:30 AM EST - 6 months ago

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

2025-11-26T22:10:11.000Z - 7 months ago

Autonomix files to sell 13.5M shares of common stock for holders

Nov 26, 2025, 8:45 AM EST - 7 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

2025-11-18T15:00:39.000Z - 7 months ago

Autonomix prices 4.5M shares at $1.11 in private placement

2025-11-17T13:15:20.000Z - 7 months ago

Autonomix reports results from exploratory subgroup analysis on PoC study

Nov 12, 2025, 7:00 AM EST - 7 months ago

Autonomix Medical Quarterly report: Q2 2026

Oct 24, 2025, 9:00 AM EDT - 8 months ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 16, 2025, 9:15 AM EDT - 8 months ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

2025-10-09T12:50:09.000Z - 8 months ago

Autonomix granted U.S patent on platform enabling precision therapies

Oct 9, 2025, 8:45 AM EDT - 8 months ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 2, 2025, 8:45 AM EDT - 9 months ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

2025-09-29T13:20:31.000Z - 9 months ago

Autonomix launches GLP study for Sensing and RF ablation system

Sep 29, 2025, 9:15 AM EDT - 9 months ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

2025-09-23T21:20:18.000Z - 9 months ago

Autonomix files to sell 2.5M shares of common stock for holders

Sep 4, 2025, 9:00 AM EDT - 10 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

2025-09-03T12:41:46.000Z - 10 months ago

Autonomix announces longer-term post hoc data from PoC 1 trial

Sep 3, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 2, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

2025-08-20T21:05:09.000Z - 10 months ago

Autonomix files to sell 1.57M shares of common stock for holders

2025-08-20T12:45:20.000Z - 10 months ago

Autonomix granted new European patent for catheter-based technology

Aug 18, 2025, 9:15 AM EDT - 10 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 15, 2025, 9:00 AM EDT - 10 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

2025-08-14T12:41:02.000Z - 10 months ago

Autonomix finalizes design review of intravascular nerve sensing catheter

Aug 14, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Aug 13, 2025, 7:00 AM EDT - 10 months ago

Autonomix Medical Quarterly report: Q1 2026

Jul 22, 2025, 8:45 AM EDT - 11 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

2025-07-22T12:40:55.000Z - 11 months ago

Autonomix announces exercise of warrants for $2.5M gross proceeds

2025-07-21T12:53:24.000Z - 11 months ago

Autonomix granted new U.S. patent on smart torquer device

Jul 21, 2025, 8:45 AM EDT - 11 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

2025-07-07T12:40:09.000Z - 1 year ago

Autonomix releases next CEO Corner segment

Jun 30, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 5, 2025, 8:45 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

May 29, 2025, 7:00 AM EDT - 1 year ago

Autonomix Medical Annual report: Q4 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 14, 2025, 9:20 AM EDT - 1 year ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 13, 2025, 9:20 AM EDT - 1 year ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 5, 2025, 8:30 AM EDT - 1 year ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 1, 2025, 9:25 AM EDT - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 17, 2025, 5:00 PM EDT - 1 year ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 8, 2025, 8:15 AM EDT - 1 year ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 3, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 14, 2025, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Feb 20, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 13, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 7:00 AM EST - 1 year ago

Autonomix Medical Quarterly report: Q3 2025

Jan 24, 2025, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 17, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 15, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

focafoca99 Jun. 10 at 1:22 PM

$AMIX highlights its growing scientific and clinical recognition as its nerve‑sensing platform secures multiple conference abstracts and a

0 · Reply

dwhall5056 Jun. 10 at 1:21 PM

1 · Reply

coolmate25 Jun. 4 at 5:52 PM

$AMIX News after news but still down ? I mean seriously? Can't believe what are these big whales waiting for ?

1 · Reply

coolmate25 Jun. 4 at 2:01 PM

$AMIX

0 · Reply

coolmate25 Jun. 4 at 1:25 PM

$AMIX

1 · Reply

coolmate25 Jun. 2 at 4:27 PM

$AMIX Autonomix medical may be granted an additional 180-day period by July 13 from nasdaq if they apply soon and this might trigger the price to $2 .

1 · Reply

coolmate25 Jun. 1 at 7:25 PM

$AMIX There's always this one Mother trucker that sells when it's finally breathing lol but anyway soon things will be different.

0 · Reply

coolmate25 Jun. 1 at 6:57 PM

$AMIX Good earnings soon , also the De-Novo news can come at anytime .

0 · Reply

d_risk May. 29 at 11:49 AM

1 · Reply

dwhall5056 May. 28 at 3:28 PM

0 · Reply

VinWeezel May. 27 at 11:09 PM

$AMIX https://www.stocktitan.net/sec-filings/AMIX/10-k-autonomix-medical-inc-files-annual-report-45bf277e6990.html

0 · Reply

coolmate25 May. 27 at 8:02 PM

$AMIX I bought a total of 90K shares today .

0 · Reply

coolmate25 May. 27 at 6:54 PM

$AMIX Such a good stock but not good people trading, selling for pennies that shows how cheap they are , I mean seriously? Also the MM hasn't been justifying this stock properly. These stocks are totally investors and news dependents still not holding? Can't believe

0 · Reply

dwhall5056 May. 27 at 1:43 PM

$AMIX What steps are being taken to file International Patents where Autonomix's technology may be used? ie: international patents are needed for commercialization in other countries because a patent granted in one country does not provide protection in others. To protect your invention globally, you must file for patents in each country where you plan to sell your product.

0 · Reply

coolmate25 May. 26 at 7:00 PM

$AMIX Should hit $1 soon , very under valued , can't believe.

0 · Reply

frchmn May. 26 at 5:24 PM

$AMIX rocket fuel

0 · Reply

VinWeezel May. 23 at 3:25 PM

$AMIX I think this will run to mid .80s soon. Series c warrants excersizeable at .86.

0 · Reply

GaryBx105 May. 22 at 6:25 PM

$AMIX climbing wall of worry created by past declines while news was always encouraging. Yes they will need to raise cash along the way but this technology when mature should be valued at several hundreds of million$ (think Watchman) compared to current market cap of $5M. Best practices study should be completed soon paving the way to begin P3 study later this year.

0 · Reply

FibonacciTrader_ May. 22 at 4:58 PM

There are always more stocks than capital can properly manage — that’s the reality of trading Right now, my focus stays tight on these names: $ALP $AMIX $VRAX $HTCR No overtrading, no scattered attention — just clean execution on a small watchlist. That’s what separates consistency from chaos in this market

2 · Reply

coolmate25 May. 22 at 4:32 PM

$AMIX lots of sell offs happened today on all because of long weekend , hopefully it will be recovered by Tuesday.

0 · Reply

BillionaireMotion May. 21 at 11:33 PM

You miss all the insane 1,00%+ squeezers recently ??! Make sure ticker EZRA is on watch ! Starting to make a move now and breakout! Looks like shorts could get squeezed hard.. EZRA has 515k shares remaining to the public only. perfect recipe for a monster Would not be shocked at all if it runs soon. Always try to buy them early before the crowd 💎 Active volume today on $MDAI $MDTX.X $AMIX l

0 · Reply

dwhall5056 May. 21 at 8:25 PM

$AMIX wow - if the dark pool is really short 1.5 million shares, when do they cover? https://fintel.io/ss/us/amix

1 · Reply

Market Cap	2.80M
Revenue (ttm)	0.00
Net Income (ttm)	-16.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	98,500
Avg Vol	858,976
Day's Range	N/A - N/A
Shares Out	6.91M
Stochastic %K	18%
Beta	-1.43
Analysts	Strong Sell
Price Target	$2.80